Alex 2 and S extended for 96 weeks | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  9591 of 9595  at  3/15/2019 1:39:57 PM  by

map.here


 In response to msg 9589 by  lysander_us
view thread

Re: Alex 2 and S extended for 96 weeks

The win-win applies to the patient who receives drug at no charge for 96 weeks and BCRX who gets more data and can transfer the patients into customers at the end of the trial (and arguably keeps ~340+ Hae patients off the market). Enrollment for S went from 160 to 225 and we have 120 on Apex 2.

Nothing changes for BCRX regarding 2Q data release.

https://www.clinicaltrials.gov/ct2/history/NCT03485911?A=1&B=18&C=Side-by-Side#StudyPageTop

https://www.clinicaltrials.gov/ct2/history/NCT03472040?A=1&B=9&C=Side-by-Side#StudyPageTop


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 115
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
9592 Re: Alex 2 and S extended for 96 weeks lysander_us 0 3/15/2019 1:49:17 PM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...